참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Nitromethane | HCID 6375 | — |
| 반응물 | Sodium hydride | HCID 24758 | — |
| 반응물 | Hydride | HCID 166653 | — |
| 반응물 | 7-chloro-2-di-(morpholino)phosphinyloxy-5-phenyl-3H-1,4-benzodiazepin | HCID 14907886 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 7-Chloro-1,3-dihydro-2-nitromethylene-5-phenyl-2H-1,4-benzodiazepine | HCID 70053732 | — |
반응 단계
To a mixture of 1.0 ml. of nitromethane and 5 ml. of dry dimethylformamide was added 53 mg. of a 50% dispersion of sodium hydride in mineral oil (1.1 mmole hydride). After 1 hour at room temperature, under nitrogen, 489 mg. (1.0 mmole) of 7-chloro-2-di-(morpholino)phosphinyloxy-5-phenyl-3H-1,4-benzodiazepine was added. After stirring at room temperature for 2 hours, dimethylformamide was evaporated (about 80°). The residue was partitioned between methylene chloride and an aqueous layer which is acidified with a slight excess of acetic acid. The methylene chloride layer was dried (Na2SO4) and evaporated. Separation of the product mixture by preparative tlc (silica gel, developed in 10% methanol in ethylacetate v/v) afforded pure final product, which upon crystallization from methanol, had a m.p. of 178°-180°.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04739049 |
|---|
| 출처 데이터셋 | uspto-grants-1988_04 |
|---|
| ORD ID | ord-e23de29fe43843a3aa50a16921825b2f |
|---|
| 출처 메모 | uspto-grants-1988_04 |
|---|